Corcept Therapeutics, Inc. (CORT)
56.37
-1.93
(-3.31%)
USD |
NASDAQ |
May 15, 16:00
56.40
+0.02
(+0.04%)
After-Hours: 20:00
Corcept Therapeutics Profit Margin (Quarterly) : -18.92% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Merck & Co., Inc. | -26.19% |
| Supernus Pharmaceuticals, Inc. | -1.10% |
| Terns Pharmaceuticals, Inc. (DELISTED) | -- |
| Assertio Holdings, Inc. | -189.8% |
| Nektar Therapeutics | -413.4% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 7.21% |
| Return on Assets | 5.66% |
| Return on Invested Capital | 7.13% |
| Gross Profit Margin (Quarterly) | 98.25% |
| Operating Margin (Quarterly) | -30.08% |
| Return on Net Operating Assets | 48.35% |